Synthesis and opioid binding activity of dermorphin analogues containing cyclic β-amino acids

Neuropeptides

Volumn 31, Issue 4, 1997, Pages 367-372

  Bozu B ^a   Fulop F ^b   Toth G K ^a   Toth G ^b   Szucs M ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BETA AMINO ACID; DELTA OPIATE RECEPTOR; DERMORPHIN DERIVATIVE; MORPHICEPTIN; MU OPIATE RECEPTOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

EID: 0030803817     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90073-1     Document Type: Article

References (36)

1. Mansour A, Hoversten M T, Taylor L P, Watson S J, Akil H. The cloned μ, δ and κ receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res 1995; 700: 89-98.
2. Schiller P W. Development of receptor-specific opioid peptide analogues. In: Ellis G P, West G B ed. Progress in Medicinal Chemistry. Amsterdam: Elsevier Science Publishers, B.V. 1991; 2: 301-340.
3. Hruby V J, Hadley M E. Binding and information transfer in conformationally restricted peptides. In: Design and Synthesis of Organic Molecules Based on Molecular Recognition. Heidelberg: Springer Verlag, 1986: 269-299.
4. Schiller P W, Weltrowska G, Nguyen T M-D et al. Conformational Restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity. J Med Chem 1991; 34: 3125-3132.
5. Goodman M, Ro S. Peptidomimetics for drug design. In: Wolff ME, ed. Burger's Medicinal Chemistry and Drug Discovery, Vol 1. John Wiley & Sons 1995: 803-861.
6. Yamazaki T, Zhu Y-F, Probstl A, Chadha R K, Goodman M. Probing a molecular model of taste utilizing peptidomimetic stereoisomers of 2-aminocyclopentanecarboxylic acid methyl ester. J Org Chem 1991; 56: 6644-6655.
7. Deeks T, Crooks P A, Waigh R D. Synthesis and analgesic properties of two leucine-enkephalin analogues containing a conformationally restrained N-terminal tyrosine residue. J Med Chem 1983; 26: 762-765.
8. 4] morphiceptin analogs incorporating cis-2 aminocyclopentane carboxylic acid as a peptidomimetic for proline. Int J Pept Protein Res 1991; 37: 364-381.
9. Erspamer V, Melchiorri P. Active polypeptides: from amphibian skin to gastrointestinal tract and brain of mammals. Trends Pharmacol Sci 1980; 1: 391-395.
10. Brantl V, Teschemacher H, Blasig J, Henschen A, Lottspeich F. Opioid activities of β-casomorphins. Life Sci 1981; 28: 1903-1909.
11. Mierke D F, Nöbner G, Schiller P W, Goodman M. Morphiceptin analogs containing 2-aminocyclopentane carboxylic acid as a peptidomimetic for proline. Int J Pept Protein Res 1990; 35: 35-45.
12. 3H]Ile5,6Deltorphin II. Neuropeptides 1994; 26: 261-265.
13. Moriconi E J, Crawford W C. The reaction of chlorosulfonyl isocyanate with bridged bi- and tricyclic olefins. J Org Chem 1968; 33: 370-378.
14. Stájer G, Szabó A E, Fülöp F, Bernáth G, Sohár P. Preparation and steric structures of dihydro-1,3-oxanines, 1,3-oxanin-2-ones and -2-thiones fused with norbornane and norbornene. J Heterocyclic Chem 1983; 20: 1181-1185.
15. Bernáth G, Stájer G, Szabó A E, Fülöp F, Sohár P. Preparation and conformational study of partially saturated 3,1-benzoxanines, 3,1-benzoxazin-2-ones and 3,1-benzoxozine-2-thiones. Tetrahedron 1985; 41: 1353-1365.
16. Stájer G, Mód L, Szabó A E, Fülöp F, Bernáth G, Sohár P. Synthesis and kinetic study on the retrodiene decomposition of norbornene-condensed 1,3-oxazin-4-ones. Tetrahedron 1984; 40: 2385-2393.
17. Merrifield R B. The synthesis of a tetrapeptide. Solid phase peptide synthesis. J Am Chem Soc 1963; 85: 2149-2154.
18. Kaiser E, Choleschott R L, Bosshinger C D, Cook P J. Colour test for the detection of free amino groups in the solid phase synthesis of peptides. Anal Chem 1970; 34: 595-598.
19. Szücs M, Coscia C J. Evidence for δ-opioid binding and GTP-regulatory proteins in 5-day-old rat brain membranes. J Neurochem 1990; 54: 1419-1425.
20. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye-binding. Anal Biochem 1986; 72: 248-254.
21. Munson P J, Rodbard D. LIGAND: a versatile computerised approach for the characterization of ligand binding studies. Anal Biochem 1980; 107: 220-227
22. Charpentier S, Sagan S, Delfour A, Nicolas P. Dermenkephalin and deltorphin I reveal similarities within the ligand-binding domains of μ- and δ-opioid receptors and an additional address subsite on the δ-receptor. Biochem Biophys Res Commun 1991; 179: 1161-1168.
23. Liebmann C, Szücs M, Neubert K, Hartrodt B, Arold H, Brath A. Opiate receptor binding affinities of some D-amino acid substituted β-casomorphin analogs. Peptides 1985; 7: 195-199.
24. Portoghese P S. Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists. Trends Pharmacol Sci 1989; 10: 230-235.
25. Kieffer B L, Befort K, Gaveriaux-Ruff C, Hirth C G. The delta opioid receptor: isolation of a cDNA expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 1992; 89: 12048-12052.
26. Evans C J, Keith D E Jr, Morrison H, Magendzo K, Edwards R H. Cloning of a delta opioid receptor by functional expression. Science 1992; 258: 1952-1955.
27. Thompson R C, Mansour A, Akil H, Watson S J. Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron 1993; 11: 903-913.
28. Reisine T, Bell G. Molecular biology of opioid receptors. Trends Neurosci 1993; 16: 506-510.
29. Surratt C K, Johnson P S, Moriwaki A et al. μ opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J Biol Chem 1994; 269: 20548-20553.
30. Morley J S. Structure-activity relationship of enkephalin-like peptides. Annu Rev Pharmacol Toxicol 1980; 20: 81-110.
31. Befort K, Tabbara L, Kling D, Maigret B, Kieffer B. Role of aromatic transmembrane residues of the δ-opioid receptor in ligand recognition. J Biol Chem 1986; 271: 10161-10168.
32. Watson B, Meng F, Thompson R C, Akil H. Structural studies of the mu opioid receptor using chimeric constructs. Analgesia 1995; 1/4-6: 825-828.
33. Brandt W, Stoldt M and Schinke H. A model of the δ opioid receptor pharmacophore conformations of cyclic β-casomorphin analogues. Analgesia 1995; 1/ 4-6: 327-330.
34. Raynor K, Kong H, Chen Y et al. Pharmacological characterization of the cloned κ, δ and μ-opioid receptors. Mol Pharmacol 1993; 45: 330-334.
35. Pasternak G W. Multiple μ opiate receptors: biochemical and pharmacological evidence for multiplicity. Biochem Pharmacol 1986; 35: 361-364.
36. Mansour A, Hoversten M T, Mansson E, Bare L, Watson S J, Akil H. Apparent evidence of receptor subtypes: receptor binding studies with the cloned rat and human kappa receptors. Analgesia 1995; 1/4-6: 553-556.